Indication

Plaque psoriasis

Plaque psoriasis, or psoriasis vulgaris, is a chronic immune-mediated inflammatory disorder primarily affecting the skin, most frequently diagnosed in adults. Read more about Plaque psoriasis

922 drugs 213 manufacturers

Advertisement

Drugs that treat it

Common Plaque psoriasis therapies.

Showing 64–72 of 922 drugs

FLUOCINONIDE

TOPICAL CORTICOSTEROIDS·PYODERMA GANGRENOSUM·+13
TEVA USA
Filter & compare in the drug finder →Opens the drug finder with Plaque psoriasis preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Plaque psoriasis.

Plaque psoriasis, or psoriasis vulgaris, is a chronic immune-mediated inflammatory disorder primarily affecting the skin, most frequently diagnosed in adults.

Pathophysiologically driven by dysregulated T-cell activation and cytokine signaling—notably involving the IL-23/IL-17 and TNF pathways—the condition induces marked keratinocyte hyperproliferation and impaired epidermal maturation.

Clinically, it presents as well-demarcated, raised, erythematous or hyperpigmented plaques covered with overlying silvery-white scales.

Lesions typically manifest symmetrically across extensor surfaces such as the elbows and knees, the scalp, and the lumbosacral region, often accompanied by pruritus, pain, and nail dystrophies.

Personalize your experience

Follow Plaque psoriasis and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it